Canada missing out on pharmaceutical research
News | 11 January 2013
(John Bergeron): Canada is a strong nation economically, with a $1.7-trillion gross domestic product and spending on research and development in excess of $30 billion annually. By any measure these numbers are among the best in the world.
Click on the link to read the full article at McGill Reporter
(This link will open in a new window)
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
